These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23116458)

  • 1. A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease.
    Moss DE; Fariello RG; Sahlmann J; Sumaya I; Pericle F; Braglia E
    Br J Clin Pharmacol; 2013 May; 75(5):1231-9. PubMed ID: 23116458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methanesulfonyl fluoride (MSF): a double-blind, placebo-controlled study of safety and efficacy in the treatment of senile dementia of the Alzheimer type.
    Moss DE; Berlanga P; Hagan MM; Sandoval H; Ishida C
    Alzheimer Dis Assoc Disord; 1999 Jan; 13(1):20-5. PubMed ID: 10192638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.
    Moss DE; Perez RG; Kobayashi H
    J Alzheimers Dis; 2017; 55(3):1285-1294. PubMed ID: 27858711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic methanesulfonyl fluoride enhances one-trial per day reward learning in aged rats.
    Malin DH; Plotner RE; Radulescu SJ; Ferebee RN; Lake JR; Negrete PG; Schaefer PJ; Crothers MK; Moss DE
    Neurobiol Aging; 1993; 14(4):393-5. PubMed ID: 8367021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In utero methanesulfonyl fluoride differentially affects learning and maze performance in the absence of long-lasting cholinergic changes in the adult rat.
    Carcoba LM; Santiago M; Moss DE; Cabeza R
    Pharmacol Biochem Behav; 2008 Feb; 88(4):374-84. PubMed ID: 17920111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methanesulfonyl fluoride, an acetylcholinesterase inhibitor, attenuates simple learning and memory deficits in ischemic rats.
    Borlongan CV; Sumaya IC; Moss DE
    Brain Res; 2005 Mar; 1038(1):50-8. PubMed ID: 15748872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methanesulfonyl fluoride (MSF) blocks scopolamine-induced amnesia in rats.
    Palacios-Esquivel RL; Pacheco G; Moss DE
    Neurobiol Aging; 1993; 14(1):93-6. PubMed ID: 8450938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.
    Imbimbo BP
    CNS Drugs; 2001; 15(5):375-90. PubMed ID: 11475943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study.
    Cutler NR; Jhee SS; Cyrus P; Bieber F; TanPiengco P; Sramek JJ; Gulanski B
    Life Sci; 1998; 62(16):1433-41. PubMed ID: 9585171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.
    Doody RS; Corey-Bloom J; Zhang R; Li H; Ieni J; Schindler R
    Drugs Aging; 2008; 25(2):163-74. PubMed ID: 18257603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NXX-066 in patients with Alzheimer's disease: a bridging study.
    Sramek JJ; Hourani J; Jhee SS; Cutler NR
    Life Sci; 1999; 64(14):1215-21. PubMed ID: 10210264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.
    Rogers SL; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):1-6. PubMed ID: 9839758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiple-dose safety trial of eptastigmine in Alzheimer's disease, with pharmacodynamic observations of red blood cell cholinesterase.
    Sramek JJ; Block GA; Reines SA; Sawin SF; Barchowsky A; Cutler NR
    Life Sci; 1995; 56(5):319-26. PubMed ID: 7837931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses.
    Rogers SL; Cooper NM; Sukovaty R; Pederson JE; Lee JN; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):7-12. PubMed ID: 9839759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease.
    Pettigrew LC; Bieber F; Lettieri J; Wermeling DP; Schmitt FA; Tikhtman AJ; Ashford JW; Smith CD; Wekstein DR; Markesbery WR; Orazem J; Ruzicka BB; Mas J; Gulanski B
    J Clin Pharmacol; 1998 Mar; 38(3):236-45. PubMed ID: 9549662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers.
    Mant T; Troetel WM; Imbimbo BP
    J Clin Pharmacol; 1998 Jul; 38(7):610-7. PubMed ID: 9702845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABT-126 monotherapy in mild-to-moderate Alzheimer's dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension.
    Gault LM; Lenz RA; Ritchie CW; Meier A; Othman AA; Tang Q; Berry S; Pritchett Y; Robieson WZ
    Alzheimers Res Ther; 2016 Oct; 8(1):44. PubMed ID: 27756421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physostigmine for Alzheimer's disease.
    Coelho F; Birks J
    Cochrane Database Syst Rev; 2001; 2001(2):CD001499. PubMed ID: 11405996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.
    Xiao S; Wang T; Ma X; Qin Y; Li X; Zhao Z; Liu X; Wang X; Xie H; Jiang Q; Sun L; Luo B; Shang L; Chen W; Bai Y; Tang M; He M; Wu L; Ma Q; Hou D; He J
    Age Ageing; 2017 Sep; 46(5):767-773. PubMed ID: 28419192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.